Promising results from Viaskin patch research.
Peanut oral immunotherapy in a capsule is moving closer to regulatory approval in the United States. The therapy brings hope – not for a cure – but of lives made less vulnerable.
Why FARE (Food Allergy Research & Education) thinks desensitization is a vital food allergy therapy on the path toward finding tolerance.
In a long-term follow-up study, oral immunotherapy (OIT) patients who were treated for up to five food allergies were able to maintain a high level of desensitization to their allergens, even those taking very low “doses” of their allergens.
They’re the courageous food allergy parents and children testing therapies still in the experimental stages.
Patients taking the drug had one-third the number of reactions of a placebo group while doing OIT
Dr. Brian Vickery was interested in cardiology before he spent time as a pediatric resident in New York City. There,… Read more »
Testing OIT in such a young population has never been done before, but results show that it’s worth it.